Amended Statement of Beneficial Ownership (3/a)
27 Décembre 2021 - 11:07PM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
THERMO FISHER SCIENTIFIC INC. |
2. Date of Event Requiring Statement (MM/DD/YYYY)
12/8/2021
|
3. Issuer Name and Ticker or Trading Symbol
Science 37 Holdings, Inc. [SNCE]
|
(Last)
(First)
(Middle)
168 THIRD AVENUE |
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director ___X___ 10% Owner _____ Officer (give title below) _____ Other (specify below)
|
(Street)
WALTHAM, MA 02451
(City)
(State)
(Zip)
| 5. If Amendment, Date Original Filed(MM/DD/YYYY) 12/20/2021
| 6. Individual or Joint/Group Filing(Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock | 17379797 | I (1)(2) | See footnote (1) |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 4) | 2. Date Exercisable and Expiration Date (MM/DD/YYYY) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) |
Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Explanation of Responses: |
(1) | These shares of common stock, par value $0.0001 per share, of Science 37 Holdings, Inc. are held of record by Pharmaceutical Product Development, LLC ("Pharma LLC"). Wildcat Acquisition Holdings (UK) Limited ("Wildcat") is the sole member of Pharma LLC; Jaguar Holding Company II ("Jaguar II") is the sole shareholder of Wildcat; Jaguar Holding Company I, LLC ("Jaguar I") is the sole shareholder of Jaguar II; Eagle Holding Company II, LLC ("Eagle II") is the sole member of Jaguar I; PPD, Inc. ("PPD") is the sole member of Eagle II; Thermo Fisher Scientific Powder US Holdings Corp. ("Powder Holdings") is the sole shareholder of PPD; and Thermo Fisher Scientific Inc. is the sole shareholder of Powder Holdings. By virtue of such relationships, each of the reporting persons may be deemed to have beneficial ownership over such shares of common stock. |
(2) | This report on Form 3 is jointly filed by the reporting persons. Each of the reporting persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Disclosure of the information required by this Form was made by Pharma LLC, Wildcat, Jaguar II, Jaguar I, Eagle II and PPD pursuant to PPD, Inc.'s Form 3 filed on October 18, 2021 and Form 3/A filed on November 8, 2021. |
Remarks: This Form 3/A amends and restates the original Form 3 filed by the reporting persons on December 20, 2021. This amendment is being filed to include Thermo Fisher Scientific Powder US Holdings Corp. as a reporting person. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
THERMO FISHER SCIENTIFIC INC. 168 THIRD AVENUE WALTHAM, MA 02451 |
| X |
|
|
Thermo Fisher Scientific Powder US Holdings Corp. 168 THIRD AVENUE WALTHAM, MA 02451 |
| X |
|
|
Signatures
|
Thermo Fisher Scientific Powder US Holdings Corp. By: /s/ Maura A. Spellman, Title: Treasurer | | 12/27/2021 |
**Signature of Reporting Person | Date |
Thermo Fisher Scientific Inc. By: /s/ Anthony H. Smith, Title: Vice President, Tax and Treasury and Treasurer | | 12/27/2021 |
**Signature of Reporting Person | Date |
LifeSci Acquisition II (NASDAQ:LSAQ)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
LifeSci Acquisition II (NASDAQ:LSAQ)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024
Real-Time news about LifeSci Acquisition II Corporation (NASDAQ): 0 recent articles
Plus d'articles sur Science 37 Holdings, Inc.